hydrochlorothiazide has been researched along with moexipril in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hayashi, CM; Lakatos, I; McClelland, DL; Rosenkranz, RP | 1 |
| Aarsland, T; Dickstein, K; Ferrari, P; Stimpel, M; Todd, M | 1 |
| Chrysant, SG; Fox, AA; Stimpel, M | 1 |
| Fox, AA; Stimpel, M; White, WB | 1 |
| Stimpel, M; White, WB | 1 |
| Persson, B; Stimpel, M | 1 |
| Chrysant, SG; Stimpel, M | 2 |
| Angehrn, JC; Bonn, R; Cawello, W; De Schepper, PJ; Hutt, V; Michaelis, K; Salomon, P; Verbesselt, R | 1 |
| Koch, B; Stimpel, M | 1 |
| Jee, WS; Liang, H; Ma, YF; Pun, S; Stimpel, M | 1 |
| Friehe, H; Gietl, R; Ney, P | 1 |
| Koch, B; Oparil, S; Stimpel, M | 1 |
| Koch, B; Stimpel, M; White, WB | 1 |
| Atmaca, S; Cetin, SM; Ertürk, S | 1 |
| Chrysant, GS; Chrysant, SG | 1 |
| Belousov, IuB; Demidova, MA; Leonova, MV; Tarasov, AV | 1 |
| Andreevskaia, EM; Burkov, SG; Ivleva, AIa | 1 |
| Elaziz, OA; Farouk, M; Hemdan, A; Shehata, MA; Tawakkol, SM | 1 |
2 review(s) available for hydrochlorothiazide and moexipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological and clinical profile of moexipril: a concise review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bone and Bones; Diuretics; Drug Combinations; Heart; Humans; Hydrochlorothiazide; Hypertension; Kidney; Liver; Multicenter Studies as Topic; Prodrugs; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 2004 |
12 trial(s) available for hydrochlorothiazide and moexipril
| Article | Year |
|---|---|
Comparison of the efficacy of three dose levels of moexipril versus placebo as add-on therapy to hydrochlorothiazide in patients with moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines | 1994 |
Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Renin; Tetrahydroisoquinolines; Verapamil | 1995 |
Long-term efficacy and safety of moexipril in the treatment of hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Tetrahydroisoquinolines | 1994 |
Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Prognosis; Tetrahydroisoquinolines | 1995 |
Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Prodrugs; Single-Blind Method; Tetrahydroisoquinolines | 1996 |
A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Delayed-Action Preparations; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Verapamil | 1996 |
Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Diuretics; Drug Interactions; Humans; Hydrochlorothiazide; Isoquinolines; Male; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1996 |
Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Metoprolol; Middle Aged; Tetrahydroisoquinolines | 1997 |
Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Placebos; Racial Groups; Sex Factors; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1998 |
Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Cholesterol; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Lipids; Middle Aged; Postmenopause; Prospective Studies; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Uric Acid | 1998 |
Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Middle Aged; Prodrugs; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1997 |
[Preventive pharmacotherapy in arterial hypertension: problems of clinical assessment of drugs in women].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Tetrahydroisoquinolines; Treatment Outcome | 2009 |
10 other study(ies) available for hydrochlorothiazide and moexipril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Diuretic effects of an ACE inhibitor, RS-10085, and hydrochlorothiazide in the spontaneously hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Hydrochlorothiazide; Hypertension; Isoquinolines; Male; Natriuresis; Rats; Rats, Inbred SHR; Tetrahydroisoquinolines | 1989 |
Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bone and Bones; Bone Diseases, Metabolic; Diuretics; Drug Therapy, Combination; Female; Hydrochlorothiazide; Isoquinolines; Ovariectomy; Rats; Rats, Inbred SHR; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines; Time Factors | 1997 |
Preclinical safety studies of the combination moexipril hydrochloride/hydrochlorothiazide.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Autonomic Nervous System; Cardiovascular System; Central Nervous System; Diuretics; Drug Combinations; Electrolytes; Female; Guinea Pigs; Hemodynamics; Hydrochlorothiazide; Intestinal Mucosa; Intestines; Isoquinolines; Lung; Mice; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Tetrahydroisoquinolines | 1998 |
Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods.
Topics: Chromatography, High Pressure Liquid; Hydrochlorothiazide; Spectrophotometry, Ultraviolet; Tablets; Technology, Pharmaceutical; Tetrahydroisoquinolines | 2003 |
[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation | 2006 |
Comparative study between univariate spectrophotometry and multivariate calibration as analytical tools for simultaneous quantitation of Moexipril and Hydrochlorothiazide.
Topics: Antihypertensive Agents; Calibration; Hydrochlorothiazide; Least-Squares Analysis; Limit of Detection; Spectrophotometry; Tablets; Tetrahydroisoquinolines | 2014 |